A de-risked path to European medical cannabis at scale

Secure, compliant, and investment-ready cultivation in the EU’s fastest-growing medical cannabis market.

https://kenevir-medical.de/wp-content/uploads/2025/11/what_makes_img-2.png

Capital, assets and milestones at a glance.

From ownership to operations, every step is transparent, certified, and science-led.

  • USD 6.66 M

    Total start-up requirement

  • USD 5.17 M

    CapEx

  • USD 1.34 M

    6-month OpEx

  • USD 0.15 M

    Consulting & advisory

  • ~68,000 m²

    Owned land

  • USD 6.66 M

    Total start-up requirement

Project Readiness Overview

Key milestones completed and upcoming actions at a glance

What’s Ready
  • Land titles & maps

  • Floorplan and flows

  • Gazette license framework

  • Costed BoM (Bill of Materials)

  • GU partnership in place

What’s Next
  • GU fixed-price finalization

  • Build start

  • EU-GMP audit

  • Initial batch release

Governance & Protections

Investor rights
  • Oversight on budget, M&A, and debt issuance
  • Monthly and quarterly performance reporting
  • Representation on an advisory board

Access the Data Room

Ownership, design, and funding transparency — verified, documented, and ready for audit.

Land/law docs

Verified land titles, ownership records, and legal framework.

CapEx sheets

Detailed cost breakdown and budget validation (Scenario B).

GMP plan

EU-GMP compliance roadmap, process flows, and audit preparation.

Risk register

Comprehensive risk assessment and mitigation tracking.

GMP plan

EU-GMP compliance roadmap, process flows, and audit preparation.

This is not an offer to sell securities. Information for professional investors only.